Paper · 39409019
Systems Biology Methods via Genome-Wide RNA Sequences to Investigate Pathogenic Mechanisms for Identifying Biomarkers and Constructing a DNN-Based Drug-Target Interaction Model to Predict Potential Molecular Drugs for Treating Atopic Dermatitis.
Chou SP and 2 others. Int J Mol Sci, 2024. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Systems Biology Methods via Genome-Wide RNA Sequences to Investigate Pathogenic Mechanisms for Identifying Biomarkers and Constructing a DNN-Based Drug-Target Interaction Model to Predict Potential Molecular Drugs for Treating Atopic Dermatitis. Papers, record 39409019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39409019
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Systems Biology Methods via Genome-Wide RNA Sequences to Investigate Pathogenic Mechanisms for Identifying Biomarkers and Constructing a DNN-Based Drug-Target Interaction Model to Predict Potential Molecular Drugs for Treating Atopic Dermatitis.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dermatitis, Atopic | Major topic |
| Biomarkers | Major topic |
| Systems Biology | Major topic |
| Humans | |
| Gene Regulatory Networks | |
| Neural Networks, Computer | |
| Signal Transduction | |
| Genome-Wide Association Study | |
| Epigenesis, Genetic |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References111
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17,176,475 | Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell. | Cell Div | 2006 | https://conductscience.org/library/papers/17176475 | PubMed |
| 2 | 17,207,173 | Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis. | J Eur Acad Dermatol Venereol | 2007 | https://conductscience.org/library/papers/17207173 | PubMed |
| 3 | 20,956,546 | STAT6-mediated displacement of polycomb by trithorax complex establishes long-term maintenance of GATA3 expression in T helper type 2 cells. | J Exp Med | 2010 | https://conductscience.org/library/papers/20956546 | PubMed |
| 4 | 37,371,627 | Genetic and Epigenetic Host-Virus Network to Investigate Pathogenesis and Identify Biomarkers for Drug Repurposing of Human Respiratory Syncytial Virus via Real-World Two-Side RNA-Seq Data: Systems Biology and Deep-Learning Approach. | Biomedicines | 2023 | https://conductscience.org/library/papers/37371627 | PubMed |
| 5 | 26,400,175 | PubChem Substance and Compound databases. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/26400175 | PubMed |
| 6 | 37,799,373 | The long-term safety of topical corticosteroids in atopic dermatitis: A systematic review. | Skin Health Dis | 2023 | https://conductscience.org/library/papers/37799373 | PubMed |
| 7 | 10,856,136 | IL-4/IL-13 signaling beyond JAK/STAT. | J Allergy Clin Immunol | 2000 | https://conductscience.org/library/papers/10856136 | PubMed |
| 8 | 31,920,718 | Interleukin-5 in the Pathophysiology of Severe Asthma. | Front Physiol | 2019 | https://conductscience.org/library/papers/31920718 | PubMed |
| 9 | 14,681,454 | The Database of Interacting Proteins: 2004 update. | Nucleic Acids Res | 2004 | https://conductscience.org/library/papers/14681454 | PubMed |
| 10 | 11,923,161 | Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. | BMJ | 2002 | https://conductscience.org/library/papers/11923161 | PubMed |
1 to 10 of 111
See all 111 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42,696,144 | Neuroimmune pharmacotherapy across the skin-brain axis: mechanisms, therapeutic targets, and AI-enabled precision approaches. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42696144 |
Source PubMed
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| GATA3 | 2,625 | PubTator's text mining | https://conductscience.org/library/genes/2625 | NCBI Gene |
| IL1B | 3,553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| NFKB1 | 4,790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39409019
GET https://conductscience.org/api/papers/v1/39409019/references?page=2